{
  "ticker": "FRE",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966358",
  "id": "02966358",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250704",
  "time": "1737",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lhc1rz36x5zx.pdf",
  "summary": "**Summary of Firebrick Pharma ASX Announcement (4 July 2025):**\n\n- **Capital Raising (Placement):** Issued 2,745,240 shares at $0.063/share, raising **~$173k**.  \n- **Issue Context:** Shares issued due to failed investor commitments via Lead Manager (Report Card Pty Ltd).  \n- **Disclosure Exemption:** Issued under Section 708A (no disclosure to investors under Part 6D.2).  \n\nNo other material financial, operational, or timetable details provided.",
  "usage": {
    "prompt_tokens": 925,
    "completion_tokens": 115,
    "total_tokens": 1040,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-04T08:59:49.079825"
}